Company that mixed diluted drugs not in ‘grey’ area, but fixes needed: expert

TORONTO — The expert investigating diluted chemotherapy drugs says he personally doesn’t feel companies that mix drugs for hospitals fell into a jurisdictional grey area.

Afficher le reportage au complet